Tomás-Rodríguez María Isabel, Palazón-Bru Antonio, Martínez-St John Damian Robert James, Toledo-Marhuenda José Vicente, Asensio-García María Del Rosario, Gil-Guillén Vicente Francisco
Department of Pathology and Surgery, Miguel Hernández University, San Juan de Alicante, Alicante, Spain.
Department of Clinical Medicine, Miguel Hernández University, San Juan de Alicante, Alicante, Spain.
Sci Rep. 2015 Nov 13;5:16671. doi: 10.1038/srep16671.
In 2014, we assessed the effectiveness of Medical Taping Concept (MTC) in Primary Dysmenorrhoea (PD) with a single-blind, two-armed clinical trial (NCT02114723, ClinicalTrials.gov) with a follow-up of 4 menstrual cycles (pre-intervention: 2 months; post-intervention: 2 months) in a sample formed by 129 Spanish women aged 18-30 years with PD. We had two groups: intervention group (75), MTC covering T-11 and T-12 dermatomes; control group (54), another taping in both greater trochanter areas. Our main outcome measures were: pre-intervention and post-intervention increase in pain difference measured 2 hours after commencement (2-h pain - 0-h pain); difference between the number of tablets ingested post-intervention and pre-intervention; and associated symptoms in post-intervention (fatigue, vomiting, diarrhoea, nausea and others). Pain was assessed in: abdomen, legs, head and lower back. We found significant differences (p < 0.05) for number of tablets, abdominal and leg pain. In conclusion, the intervention group had less abdominal and leg pain when pharmacological therapy was not started. Furthermore, the intervention resulted in a lower intake of tablets. Nevertheless, more studies are needed to corroborate our results and to analyze the MTC effectiveness if women do not take any tablets during the entire menstrual period.
2014年,我们采用单盲双臂临床试验(NCT02114723,ClinicalTrials.gov)对129名年龄在18至30岁患有原发性痛经(PD)的西班牙女性进行了样本研究,随访4个月经周期(干预前:2个月;干预后:2个月),评估了医用贴扎概念(MTC)对原发性痛经的疗效。我们分为两组:干预组(75人),MTC覆盖T-11和T-12皮节;对照组(54人),在双侧大转子区域进行另一种贴扎。我们的主要结局指标为:干预前和干预后开始2小时后测量的疼痛差异增加量(2小时疼痛 - 0小时疼痛);干预后和干预前摄入片剂数量的差异;以及干预后的相关症状(疲劳、呕吐、腹泻、恶心等)。在腹部、腿部、头部和下背部评估疼痛情况。我们发现片剂数量、腹部和腿部疼痛存在显著差异(p < 0.05)。总之,在未开始药物治疗时,干预组的腹部和腿部疼痛较轻。此外,干预导致片剂摄入量较低。然而,需要更多研究来证实我们的结果,并分析如果女性在整个月经期不服用任何片剂时MTC的疗效。